EU Clears AbbVie Takeover of Allergan Subject to Conditions EU Clears AbbVie Takeover of Allergan Subject to Conditions
The European Commission said on Friday it had approved U.S. drugmaker AbbVie's planned $63 billion acquisition of Botox-maker Allergan, subject to conditions.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 13, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

GP slams 'Wild West' approach to Botox - after Love Island star 'qualifies' to give treatments
Rykard Jenkins has been sharing his experience of training to become an aesthetic practitioner. However, one aesthetic doctor has criticised companies offering such training to non medics. (Source: the Mail online | Health)
Source: the Mail online | Health - November 22, 2019 Category: Consumer Health News Source Type: news

Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
IT'S BO-TIME: BRAND CELEBRATES HOLIDAY WITH EXCLUSIVE ONE-DAY-ONLY OFFER DUBLIN, Nov. 18, 2019 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN), the maker of BOTOX® Cosmetic, has announced the first-ever National BOTOX® Cos... Biopharmaceuticals, Dermatology Allergan, BOTOX, onabotulinumtoxinA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2019 Category: Pharmaceuticals Source Type: news

Why women in their 40s are seeking full-on facelifts instead of botox
Civil servant Mel Beard, 49, from West Sussex, pictured left before her facelift and right after the procedure said she considered going under the knife five years earlier. (Source: the Mail online | Health)
Source: the Mail online | Health - November 16, 2019 Category: Consumer Health News Source Type: news

Allergan's Botox gets pediatric approval
Allergan announced that the U.S. FDA has approved the company's supplemental BLA for Botox for the treatment of pediatric patients (2 to 17 years of age) with lower limb spasticity, excluding spasticity caused by cerebral palsy. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 25, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves Botox (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
DUBLIN, Oct. 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental Biologics License Application (sBLA) for Botox for the treatment of pediatric... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 25, 2019 Category: Drugs & Pharmacology Source Type: news

FDA Approves Botox for Lower-Limb Spasticity in Children FDA Approves Botox for Lower-Limb Spasticity in Children
The FDA has approved Botox to ease lower-limb spasticity in children and adolescents aged 2 to 17 years, excluding spasticity caused by cerebral palsy.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 24, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news

FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
Approval Marks 11th BOTOX® Therapeutic Indication and Comes 30 Years After the First Indications Were Approved DUBLIN, Oct. 24, 2019 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug A... Biopharmaceuticals, FDA Allergan, BOTOX, onabotulinumtoxinA, limb spasticity (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 24, 2019 Category: Pharmaceuticals Source Type: news

Fort Washington Man Sentenced to 66 Months in Federal Prison for Two Separate Drug Cases
Daniel Mark Wilkerson, Ft. Washington MD, prescription drugs, federal military hospitals, Rodger Gurdon, Issa Wasco Koroma, Norditropon, Humatrope, Somatotropin, Botox, human growth hormone, pharmacies, Ft. Belvoir Community Hospital VA, Walter Reed National Military Medical Center, Bethesda MD, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - October 7, 2019 Category: Medical Law Authors: DOJ Source Type: news

Botox bars raise concern among medical experts and patients
Nearly 16 million minimally invasive cosmetic procedures took place last year in the U.S. That includes nearly 7.5 million botox, and other neurotoxin injections to reduce wrinkles as well as 2.5 million filler injections to shape the face. These enhancements traditionally require a visit to a doctor's office but as Dr. Tara Narula shows us, new salons are offering injections in a more casual setting -- creating potential risks. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 2, 2019 Category: Consumer Health News Source Type: news

Botox bars raise concern among medical experts: "Things can happen"
New salons are offering the procedure in a more casual setting – but experts say there's risks (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 2, 2019 Category: Consumer Health News Source Type: news

Patients who bought a doctor’s Botox services on Groupon got phony injections, officials say
Authorities raided her Coral Springs, Fla., office earlier this week as part of a year-long investigation into her practices, local news reports say. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - September 14, 2019 Category: Consumer Health News Authors: Hannah Knowles Source Type: news

Evolus Says Launch of Its Botox Rival Ahead of Its Expectations Evolus Says Launch of Its Botox Rival Ahead of Its Expectations
Evolus Inc on Monday reported revenue of $2.3 million from early sales of its newly launched rival to Allergan Plc's Botox, ahead of its own expectations.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 14, 2019 Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine News Source Type: news

JPMorgan set to scoop record fee for Allergan sale
AbbVie’s planned $63bn purchase of the Botox-maker will earn $123m for bank (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - August 13, 2019 Category: Pharmaceuticals Source Type: news

Botox less costly but more AEs than neuromodulation
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2019 Category: Drugs & Pharmacology Source Type: news

'Dr. Lipjob' sent to jail for illegally injecting Botox
The Abbotsford woman who calls herself "Dr. Lipjob" has been sent to jail after defying a court order to stop injecting Botox and dermal fillers. (Source: CBC | Health)
Source: CBC | Health - July 30, 2019 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

The Takeaway: This dentist is filling cavities and offering botox treatments
Dr. Javod Gol at Precision Dentistry officially started offering cosmetic facial treatments in 2017 and has seen 20 percent growth in that area every year since. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 24, 2019 Category: Biotechnology Authors: Jessica Iannetta Source Type: news

Botox cousin can reduce malaria in an environmentally friendly way
(Stockholm University) Researchers at the universities in Stockholm and Lund, in collaboration with researchers from the University of California, have found a new toxin that selectively targets mosquitos. This can lead to innovative and environmentally friendly approaches to reduce malaria. The results are presented in an article published in Nature Communications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 28, 2019 Category: International Medicine & Public Health Source Type: news

Study finds selfie filters are driving young people to Botox
Researchers at Johns Hopkins show there is reason to be concerned that people may be driven to edit their own faces because they feel inadequate compared to filtered faces. (Source: the Mail online | Health)
Source: the Mail online | Health - June 27, 2019 Category: Consumer Health News Source Type: news

AbbVie takes a $63bn Botox injection
Welcome to Due Diligence, the FT’s daily deals briefing (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 26, 2019 Category: Pharmaceuticals Source Type: news

AbbVie has firm hopes for Botox-maker Allergan
Pipeline failures and drugs coming off patent lead to tie-up of pharma companies (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 26, 2019 Category: Pharmaceuticals Source Type: news

AbbVie to buy Botox maker Allergan for $63 billion
The acquisition aims to diversify AbbVie beyond its top-selling drug Humira, which will soon lose patent protection (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 25, 2019 Category: Consumer Health News Source Type: news

AbbVie buying Botox maker Allergan in $63B deal
AbbVie Inc. said it's buying Dublin, Ireland-based drug firm Allergan in a $63 billion deal. AbbVie (NYSE: ABBV), based in North Chicago, Illinois, said it's paying 0.8660 of its shares and $120.30 in cash for each Allergan (NYSE: AGN) share, for a total consideration of $188.24 per Allergan share. AbbVie said the combined companies' headquarters will remain in North Chicago. "This is a transformational transaction for both companies and achieves unique and complementary strategic objectives.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 25, 2019 Category: Pharmaceuticals Authors: Ben Miller Source Type: news

AbbVie to acquire Botox maker Allergan for $63bn
Cash and stock offer marks latest blockbuster deal in healthcare sector (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 25, 2019 Category: Pharmaceuticals Source Type: news

Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal
The transaction would give AbbVie a potent source of popular treatments as it faces the loss of patent protection for its best-selling drug, Humira. (Source: NYT Health)
Source: NYT Health - June 25, 2019 Category: Consumer Health News Authors: Michael J. de la Merced Tags: Allergan Inc Mergers, Acquisitions and Divestitures Drugs (Pharmaceuticals) AbbVie Inc Botox (Drug) Source Type: news

FDA OKs Botox for Upper Limb Spasticity in Children FDA OKs Botox for Upper Limb Spasticity in Children
Botox is the first neurotoxin to be approved in the US to treat upper limb spasticity for pediatric patients aged 2 years and older.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 24, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news

A Year After Approval, Migraine Drugs Are Changing Lives. But Insurance Battles Are Creating a Whole New Headache
Last May, the Food and Drug Administration (FDA) approved Amgen and Novartis’ Aimovig, the first drug specifically designed to prevent chronic migraines, and offered new hope to the millions of Americans regularly weathering these debilitating headaches. Just months later came two other drugs in its class, Eli Lilly’s Emgality and Teva Pharmaceuticals’ Ajovy. About a year after Aimovig hit the market, patients and doctors are reporting dramatic successes thanks to these therapies. But as insurance horror stories accumulate, and manufacturer-sponsored financial assistance programs approach their end, patie...
Source: TIME: Health - June 24, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs Source Type: news

FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
BOTOX® is the First Neurotoxin Treatment Approved to Treat Pediatric Patients, 2 to 17 Years of Age, with Upper Limb Spasticity Approval Marks 10th BOTOX® Therapeutic Indication in its 30th Anniversary Year DUBLIN, June 21, 2019 -- (Healthcar... Biopharmaceuticals, FDA Allergan, BOTOX, onabotulinumtoxinA, limb spasticity (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves Botox (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
DUBLIN, June 21, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental biologics application (sBLA) for Botox for the treatment of pediatric patients (2 to... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 21, 2019 Category: Drugs & Pharmacology Source Type: news

Botox May Help Bipolar Depression, Social Anxiety Botox May Help Bipolar Depression, Social Anxiety
In two small case series, injections of botulinum toxin into the glabellar region -- the area between the eyebrows and above the nose -- reduced symptoms of bipolar depression and social anxiety.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - May 30, 2019 Category: Psychiatry Tags: Psychiatry News Source Type: news

April 4, 2018: Canadian Pharmacist Sentenced for Distributing Counterfeit and Adulterated Botox to Local Doctors
(Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - May 16, 2019 Category: Medical Law Authors: u.s. Department of Justice Source Type: news

A Rival to Botox Invites Doctors to Party in Cancun, With Fireworks, Confetti and Social Media Posts
Plastic surgeons ’ Instagram accounts of the weekend trip didn ’ t note the drug company ’ s sponsorship, which some ethicists say should be disclosed. (Source: NYT Health)
Source: NYT Health - May 15, 2019 Category: Consumer Health News Authors: KATIE THOMAS Tags: Drugs (Pharmaceuticals) Social Media Evolus Botox (Drug) Advertising and Marketing Plastic Surgery Online Advertising Jeaveau Federal Trade Commission Instagram Inc Truth in Advertising Inc your-feed-healthcare Source Type: news

AEON Biopharma Appoints BOTOX(R) Therapeutic Head as President and Chief Executive Officer
Dynamic Industry Veteran Led Multi-Billion Dollar Therapeutic Neurotoxin Portfolio NEWPORT BEACH, Calif., May 13, 2019 -- (Healthcare Sales & Marketing Network) -- ALPHAEON Corporation announced today that its Board of Directors has named Marc Forth as... Biopharmaceuticals, Personnel AEON Biopharma, ALPHAEON, botulinum toxin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 13, 2019 Category: Pharmaceuticals Source Type: news

Allergan lifts outlook after Botox plumps quarterly earnings
Company hit by a $2.5bn charge related to clinical failure of antidepressant (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 7, 2019 Category: Pharmaceuticals Source Type: news

Health Tip: Uses for Botox
-- Botox injections work by weakening or paralyzing muscles, says MedlinePlus. Common side effects include pain, swelling or bruising at the injection site. Depending on the condition being treated, the effects of Botox can last from three to 12... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 1, 2019 Category: General Medicine Source Type: news

Health Tip: Uses for Botox
Title: Health Tip: Uses for BotoxCategory: Health NewsCreated: 5/1/2019 12:00:00 AMLast Editorial Review: 5/1/2019 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - May 1, 2019 Category: Dermatology Source Type: news

EMA Panel Recommends Nuceiva for Glabellar Lines EMA Panel Recommends Nuceiva for Glabellar Lines
A European Medicines Agency panel recommended marketing authorization for botulinum toxin type A (Nuceiva, Evolus Pharma Ltd) to temporarily correct glabellar lines in patients younger than 65 years.International Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 29, 2019 Category: Dermatology Tags: Dermatology News Alert Source Type: news

Botox and filler clinics owe 'duty of care to customers'
NHS England's medical director urges providers to join new professional regulator Related items fromOnMedica Clinicians need better options if we are to stop over-medication PM appoints UK ’s first minister for suicide prevention ‘No improvement’ in community mental health care NHS is failing patients with mental health problems Experts urge radical action on mental health crises (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 29, 2019 Category: UK Health Source Type: news

Superdrug rolls out its controversial Botox and fillers to second store in Manchester
The retailer has revealed its Manchester Piccadilly store will offer the treatments as of next week, with Botox costing £99 and fillers between £125 and £349. (Source: the Mail online | Health)
Source: the Mail online | Health - April 27, 2019 Category: Consumer Health News Source Type: news

Government will launch campaign against botched Botox and fillers
The UK's Department of Health and Social Care will warn people about the risks of dermal fillers which can cause uncontrollable swelling, as happened to Billie Roocroft and Lora Evans (pictured). (Source: the Mail online | Health)
Source: the Mail online | Health - April 22, 2019 Category: Consumer Health News Source Type: news

How painless muscle-paralysing Botox 'pistol' can stop excessive sweating without injections
In excessive sweating, Botox works to block nerve signals that instruct the sweat glands to produce liquid. Dr Rekha Tailor, a GP and aesthetic practitioner from Surrey, offers the treatment. (Source: the Mail online | Health)
Source: the Mail online | Health - April 20, 2019 Category: Consumer Health News Source Type: news

Can Botox and Cosmetic Surgery Chill Our Relationships With Others?
Experts say mirroring another person ’ s facial expressions is essential not only for recognizing emotion, but also for feeling it. (Source: NYT Health)
Source: NYT Health - April 18, 2019 Category: Consumer Health News Authors: KATE MURPHY Tags: Face Emotions Love (Emotion) Botox (Drug) Plastic Surgery Source Type: news

Americans spent a record $16.5 billion on plastic surgery last year
Botox, though one of the least expensive procedures at $397 a pop, was the biggest money grabber, taking in $2.95 billion, according to the latest American Society of Plastic Surgeons report. (Source: the Mail online | Health)
Source: the Mail online | Health - April 10, 2019 Category: Consumer Health News Source Type: news

Health Canada Plans to Suspend Allergan's Breast Implant License Health Canada Plans to Suspend Allergan's Breast Implant License
Health Canada said on Thursday it was advising Allergan Plc of the regulator's plans to suspend the license for the Botox-maker's Biocell breast implants, after a review regarding the risk of a rare cancer linked to breast implants.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 5, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Maker of Botox alternative turns toxin on crippling muscle disorder
Revance's Botox-like therapy could be used for a broad number of therapeutic as well as aesthetic uses, its leaders say. Regulators will have the final say. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 4, 2019 Category: Health Management Authors: Ron Leuty Source Type: news

Maker of Botox alternative turns toxin on crippling muscle disorder
Revance's Botox-like therapy could be used for a broad number of therapeutic as well as aesthetic uses, its leaders say. Regulators will have the final say. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 4, 2019 Category: Biotechnology Authors: Ron Leuty Source Type: news

Health Canada plans to suspend Allergan's breast implant license
Health Canada plans to suspend the license for Allergan Plc's Biocell breast implant due to the risk of a rare cancer linked to such implants, the regulator said in a notice to the Botox-maker on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - April 4, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Nurses take over therapeutic Botox clinic from Bradford doctors
Nurses in Bradford are now at the forefront of delivering Botox treatments to patients with debilitating eye conditions through a new nurse-led clinic. (Source: Nursing Times)
Source: Nursing Times - March 29, 2019 Category: Nursing Source Type: news

FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Applications Seek to Extend Use of BOTOX® for Patients 2 to 17 Years Old DUBLIN, March 7, 2019 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the c... Biopharmaceuticals, FDA Allergan, BOTOX, onabotulinumtoxin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 7, 2019 Category: Pharmaceuticals Source Type: news

Allergan depression treatment fails studies, shares slip
Allergan Plc said on Wednesday its experimental add-on treatment for depression failed three late-stage studies, casting doubts over its drugs pipeline and sending the Botox-maker's shares down nearly 4 percent after the bell. (Source: Reuters: Health)
Source: Reuters: Health - March 7, 2019 Category: Consumer Health News Tags: healthNews Source Type: news